Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 279

1.

Cytokeratin-positive interstitial reticulum cell tumor: recognition of a potential "in situ" pattern.

Bösmüller H, Klenske J, Bonzheim I, Scharpf M, Rieger N, Quintanilla-Fend L, Fend F.

Hum Pathol. 2016 Mar;49:15-21. doi: 10.1016/j.humpath.2015.10.001. Epub 2015 Oct 26.

PMID:
26826404
2.

[Tumor of the mesosalpinx with unclear differentiation].

Nann D, Gahlen S, Keul HG, Voigt HJ, Fend F, Staebler A.

Pathologe. 2016 Jan 21. [Epub ahead of print] German.

PMID:
26794496
3.

Retraction Note to: The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.

Bachmann C, Brucker SY, Kraemer B, Rothmund R, Staebler A, Fend F, Wallwiener D, Grischke EM.

J Cancer Res Clin Oncol. 2016 Feb;142(2):529. doi: 10.1007/s00432-015-2100-5. No abstract available.

PMID:
26738498
4.

Choroidal metastases from thymic carcinoma during pregnancy: Case Report.

Haen SP, Stroebel P, Marx A, Suesskind D, Fend F, Reichmann U, Kopp HG, Kanz L, Mayer F.

BMC Cancer. 2015 Dec 16;15(1):972. doi: 10.1186/s12885-015-1968-4.

5.

Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis.

Pencik J, Schlederer M, Gruber W, Unger C, Walker SM, Chalaris A, Marié IJ, Hassler MR, Javaheri T, Aksoy O, Blayney JK, Prutsch N, Skucha A, Herac M, Krämer OH, Mazal P, Grebien F, Egger G, Poli V, Mikulits W, Eferl R, Esterbauer H, Kennedy R, Fend F, Scharpf M, Braun M, Perner S, Levy DE, Malcolm T, Turner SD, Haitel A, Susani M, Moazzami A, Rose-John S, Aberger F, Merkel O, Moriggl R, Culig Z, Dolznig H, Kenner L.

Nat Commun. 2015 Oct 26;6:8802. doi: 10.1038/ncomms9802. No abstract available.

PMID:
26499136
6.

Aberrant CD68 expression is a rare pitfall in the diagnosis of primary amelanotic malignant melanoma in ascites fluid.

Krugmann J, Sterlacci W, Veits L, Vieth M, Rieker RJ, Altmann T, Sokolowski T, Fend F.

Cytopathology. 2015 Sep 25. doi: 10.1111/cyt.12269. [Epub ahead of print] No abstract available.

PMID:
26407839
7.

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma.

Fisel P, Stühler V, Bedke J, Winter S, Rausch S, Hennenlotter J, Nies AT, Stenzl A, Scharpf M, Fend F, Kruck S, Schwab M, Schaeffeler E.

Oncotarget. 2015 Oct 13;6(31):30615-27. doi: 10.18632/oncotarget.5593.

8.

Early detection of psychosis: helpful or stigmatizing experience? A qualitative study.

Uttinger M, Koranyi S, Papmeyer M, Fend F, Ittig S, Studerus E, Ramyead A, Simon A, Riecher-Rössler A.

Early Interv Psychiatry. 2015 Sep 11. doi: 10.1111/eip.12273. [Epub ahead of print]

PMID:
26362478
9.

Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.

Leinhäuser I, Richter A, Lee M, Höfig I, Anastasov N, Fend F, Ercolino T, Mannelli M, Gimenez-Roqueplo AP, Robledo M, de Krijger R, Beuschlein F, Atkinson MJ, Pellegata NS.

Oncotarget. 2015 Nov 17;6(36):39111-26. doi: 10.18632/oncotarget.4912.

10.

Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications.

Boiocchi L, Gianelli U, Iurlo A, Fend F, Bonzheim I, Cattaneo D, Knowles DM, Orazi A.

Mod Pathol. 2015 Nov;28(11):1448-57. doi: 10.1038/modpathol.2015.100. Epub 2015 Sep 4.

PMID:
26336886
11.

[Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].

Bösmüller H, Nann D, Horger M, Fend F.

Pathologe. 2015 Sep;36(5):458-66. doi: 10.1007/s00292-015-0057-4. German.

PMID:
26305142
12.

Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness.

Menegakis A, De Colle C, Yaromina A, Hennenlotter J, Stenzl A, Scharpf M, Fend F, Noell S, Tatagiba M, Brucker S, Wallwiener D, Boeke S, Ricardi U, Baumann M, Zips D.

Radiother Oncol. 2015 Sep;116(3):480-5. doi: 10.1016/j.radonc.2015.08.006. Epub 2015 Aug 18.

PMID:
26297183
13.

[Differential diagnostic specific skin infiltrates in chronic myelomonocytic leukemia].

Federmann B, Metzler G, Bonzheim I, Fend F.

Pathologe. 2015 Sep;36(5):494-7. doi: 10.1007/s00292-015-0058-3. German.

PMID:
26292933
14.

[Histiocytic disorders].

Fend F.

Pathologe. 2015 Sep;36(5):431. doi: 10.1007/s00292-015-0075-2. German. No abstract available.

PMID:
26289804
15.

STAT3 regulated ARF expression suppresses prostate cancer metastasis.

Pencik J, Schlederer M, Gruber W, Unger C, Walker SM, Chalaris A, Marié IJ, Hassler MR, Javaheri T, Aksoy O, Blayney JK, Prutsch N, Skucha A, Herac M, Krämer OH, Mazal P, Grebien F, Egger G, Poli V, Mikulits W, Eferl R, Esterbauer H, Kennedy R, Fend F, Scharpf M, Braun M, Perner S, Levy DE, Malcolm T, Turner SD, Haitel A, Susani M, Moazzami A, Rose-John S, Aberger F, Merkel O, Moriggl R, Culig Z, Dolznig H, Kenner L.

Nat Commun. 2015 Jul 22;6:7736. doi: 10.1038/ncomms8736. Erratum in: Nat Commun. 2015;6:8802.

16.

Feasibility of Penis-Preserving Surgery for Urethral Melanoma: Proposal for a Therapeutic Algorithm.

Fahmy O, Scharpf M, Fend F, Stenzl A, Gakis G.

Clin Genitourin Cancer. 2015 Dec;13(6):e411-3. doi: 10.1016/j.clgc.2015.06.003. Epub 2015 Jun 15. No abstract available.

PMID:
26164683
17.

Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study.

Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, Wieland W, Eder F, Hofstädter F, Schilling D, Sievert KD, Stenzl A, Scharpf M, Fend F, Vom Dorp F, Rübben H, Kurt Werner S, Porres-Knoblauch D, Heidenreich A, Hangarter B, Knüchel-Clarke R, Rogenhofer M, Wullich B, Hartmann A, Comploj E, Pycha A, Hanspeter E, Pehrke D, Sauter G, Graefen M, Gratzke C, Stief C, Wiegel T, Haese A.

Radiother Oncol. 2015 Jul;116(1):119-24. doi: 10.1016/j.radonc.2015.06.021. Epub 2015 Jun 29.

PMID:
26138059
18.

Role of Pelvic and Para-aortic Lymph Node Metastases in Optimally Cytoreduced Advanced Ovarian Cancer.

Bachmann C, Bachmann R, Brucker SY, Staebler A, Fend F, Grischke EM, Wallwiener D.

Anticancer Res. 2015 Jun;35(6):3479-84. Retraction in: Anticancer Res. 2015 Jul;35(7):4372.

PMID:
26026113
19.

Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.

Deml KF, Schildhaus HU, Compérat E, von Teichman A, Storz M, Schraml P, Bonventre JV, Fend F, Fleige B, Nerlich A, Gabbert HE, GaBler N, Grobholz R, Hailemariam S, Hinze R, Knüchel R, Lhermitte B, Nesi G, Rüdiger T, Sauter G, Moch H.

Am J Surg Pathol. 2015 Jul;39(7):889-901. doi: 10.1097/PAS.0000000000000456.

PMID:
25970683
20.

ALK-positive anaplastic large cell lymphoma: an evolving story.

Bonzheim I, Steinhilber J, Fend F, Lamant L, Quintanilla-Martinez L.

Front Biosci (Schol Ed). 2015 Jun 1;7:248-59. Review.

PMID:
25961700
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk